Ranibizumab is a potential prophylaxis for proliferative vitreoretinopathy, a nonangiogenic blinding disease
雷珠单抗是一种潜在的预防增生性玻璃体视网膜病变的药物,增生性玻璃体视网膜病变是一种非血管生成性致盲疾病
期刊:American Journal of Pathology
影响因子:4.7
doi:10.1016/j.ajpath.2013.01.052
Steven Pennock, David Kim, Shizuo Mukai, Matthew Kuhnle, Dal W Chun, Joanne Matsubara, Jing Cui, Patrick Ma, David Maberley, Arif Samad, Robert J Van Geest, Sarit L Oberstein, Reinier O Schlingemann, Andrius Kazlauskas